Eli Lilly and Company revenue by year
Over the 10 fiscal years shown, revenue went from $21.22B (year ended Dec 31, 2016) to $65.18B (year ended Dec 31, 2025), a compound annual growth rate of 13.3%. The fastest growth was +44.7% in the year ended Dec 31, 2025; the weakest year was −5.9% (year ended Dec 31, 2017).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $65.18B | +44.7% | Revenues | 10-K filed Feb 12, 2026 |
| Dec 31, 2024 | $45.04B | +32.0% | Revenues | 10-K filed Feb 12, 2026 |
| Dec 31, 2023 | $34.12B | +19.6% | Revenues | 10-K filed Feb 12, 2026 |
| Dec 31, 2022 | $28.54B | +0.8% | Revenues | 10-K filed Feb 19, 2025 |
| Dec 31, 2021 | $28.32B | +15.4% | Revenues | 10-K filed Feb 21, 2024 |
| Dec 31, 2020 | $24.54B | +9.9% | Revenues | 10-K filed Feb 22, 2023 |
| Dec 31, 2019 | $22.32B | +3.8% | Revenues | 10-K filed Feb 23, 2022 |
| Dec 31, 2018 | $21.49B | +7.6% | Revenues | 10-K filed Feb 17, 2021 |
| Dec 31, 2017 | $19.97B | −5.9% | Revenues | 10-K filed Feb 19, 2020 |
| Dec 31, 2016 | $21.22B | +6.3% | Revenues | 10-K filed Feb 19, 2019 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $24.40B | +38.6% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2026 | $22.97B | +47.7% | 10-Q filed Aug 5, 2026 |
| 3 months ended Mar 31, 2026 | $19.80B | +55.5% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2025 | $17.60B | +53.9% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2025 | $15.56B | +37.6% | 10-Q filed Aug 5, 2026 |
| 3 months ended Mar 31, 2025 | $12.73B | +45.2% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2024 | $11.44B | +20.4% | 10-Q filed Oct 30, 2025 |
| 3 months ended Jun 30, 2024 | $11.30B | +36.0% | 10-Q filed Aug 7, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 59478 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.